Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 32
- −8 vs. Q3 2021
- Portfolio value
- $150.2M
- −$20.7M (−12.1%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 441,000 | $21.8M | 14.5% | +117,700+36.4% | Added | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 345,900 | $19.1M | 12.7% | +95,220+38.0% | Added | History |
| ALBOAlbireo Pharma, Inc. | COM | 514,082 | $12.0M | 8.0% | +69,062+15.5% | Added | History |
| CUECue Biopharma, Inc. | COM | 829,042 | $9.38M | 6.2% | +173,857+26.5% | Added | History |
| EHCEncompass Health Corp | COM | 122,187 | $7.97M | 5.3% | +90,540+286.1% | Added | History |
| OSCROscar Health, Inc. | CL A | 925,000 | $7.26M | 4.8% | +736,600+391.0% | Added | History |
| CNVYConvey Health Solutions Holdings, Inc. | COM | 777,000 | $6.50M | 4.3% | +38,988+5.3% | Added | History |
| KZRKezar Life Sciences, Inc. | COM | 360,000 | $6.02M | 4.0% | −269,957−42.9% | Reduced | History |
| ZGNXZogenix, Inc. | COM NEW | 362,909 | $5.90M | 3.9% | −127,973−26.1% | Reduced | History |
| CRLCharles River Laboratories International, Inc. | COM | 15,481 | $5.83M | 3.9% | +15,481 | New | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 409,620 | $5.42M | 3.6% | +152,229+59.1% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 31,907 | $5.41M | 3.6% | +31,907 | New | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 1,155,300 | $4.62M | 3.1% | +420,300+57.2% | Added | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 45,000 | $4.18M | 2.8% | −108,400−70.7% | Reduced | History |
| AGLagilon health, inc. | COM | 150,000 | $4.05M | 2.7% | +40,490+37.0% | Added | History |
| MORFMorphic Holding, Inc. | COM | 72,898 | $3.45M | 2.3% | +2,898+4.1% | Added | History |
| PRQRProQR Therapeutics N.V. | SHS EURO | 356,617 | $2.86M | 1.9% | +74,361+26.3% | Added | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 128,705 | $2.81M | 1.9% | +128,705 | New | History |
| STTKShattuck Labs, Inc. | COM | 260,243 | $2.21M | 1.5% | +91,002+53.8% | Added | History |
| CGTXCognition Therapeutics Inc | COM | 301,979 | $1.91M | 1.3% | +301,979 | New | History |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 195,855 | $1.90M | 1.3% | +6,915+3.7% | Added | – |
| GMEDGlobus Medical Inc | Stock | 20,188 | $1.46M | 1.0% | +20,188 | New | History |
| ACCDAccolade, Inc. | COM | 50,000 | $1.32M | 0.9% | −47,988−49.0% | Reduced | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 17,364 | $1.32M | 0.9% | +17,364 | New | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 68,800 | $1.31M | 0.9% | −205,961−75.0% | Reduced | History |
| SIOXSio Gene Therapies Inc. | COMMON | 802,180 | $1.03M | 0.7% | +308,972+62.6% | Added | History |
| MRNAModerna, Inc. | Stock | 3,700 | $940.0K | 0.6% | +3,700 | New | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 166,775 | $564.0K | 0.4% | +166,775 | New | History |
| PRCTPROCEPT BioRobotics Corp | COM | 20,000 | $500.0K | 0.3% | +20,000 | New | History |
| XCURExicure, Inc. | COM | 2,426,508 | $490.0K | 0.3% | −2,698,492−52.7% | Reduced | History |
| ODTOdonate Therapeutics, Inc. | COM | 298,900 | $404.0K | 0.3% | +298,900 | New | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 53,815 | $358.0K | 0.2% | +53,815 | New | History |
Options (4)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Galapagos NV36315X901 | CALL | – | $11.0M |
| Prothena Corp PLCG72800908 | CALL | – | $2.57M |
| Progyny Inc74340E953 | PUT | $2.52M | – |
| West Pharmaceutical SVSC Inc955306955 | PUT | $704.0K | – |
Sold out since Q3 2021 (19)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| MTCRMetacrine, Inc. | COM | 1,145,034 | $3.93M | 2.3% | History |
| MGTXMeiraGTx Holdings plc | COM | 291,080 | $3.84M | 2.2% | History |
| HUMHumana Inc | Stock | 9,000 | $3.50M | 2.0% | History |
| AMEDAmedisys Inc | COM | 20,000 | $2.98M | 1.7% | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 15,000 | $2.72M | 1.6% | History |
| HAEHaemonetics Corp | COM | 38,319 | $2.71M | 1.6% | History |
| ABBVAbbVie Inc. | Stock | 24,800 | $2.67M | 1.6% | History |
| IRTCiRhythm Holdings, Inc. | COM | 37,396 | $2.19M | 1.3% | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 13,000 | $1.90M | 1.1% | History |
| WATWaters Corp | COM | 4,000 | $1.43M | 0.8% | History |
| UNHUnitedHealth Group Inc | Stock | 3,300 | $1.29M | 0.8% | History |
| CLLSCellectis S.A. | SPON ADS | 87,103 | $1.10M | 0.6% | History |
| ASMBAssembly Biosciences, Inc. | COM | 265,634 | $924.0K | 0.5% | History |
| ALECAlector, Inc. | COM | 27,378 | $625.0K | 0.4% | History |
| LFSTLifeStance Health Group, Inc. | COM | 38,774 | $562.0K | 0.3% | History |
| ORGOOrganogenesis Holdings Inc. | COM | 38,000 | $541.0K | 0.3% | History |
| ONCROncorus, Inc. | COM | 55,411 | $518.0K | 0.3% | History |
| MDXGMimedx Group, Inc. | COM | 44,225 | $268.0K | 0.2% | History |
| APTOAptose Biosciences Inc. | COM NEW | 70,563 | $154.0K | 0.1% | History |